BR112022002269A2 - Composição farmacêutica, e, método para preparar a composição farmacêutica - Google Patents

Composição farmacêutica, e, método para preparar a composição farmacêutica

Info

Publication number
BR112022002269A2
BR112022002269A2 BR112022002269A BR112022002269A BR112022002269A2 BR 112022002269 A2 BR112022002269 A2 BR 112022002269A2 BR 112022002269 A BR112022002269 A BR 112022002269A BR 112022002269 A BR112022002269 A BR 112022002269A BR 112022002269 A2 BR112022002269 A2 BR 112022002269A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
luliconazole
preparing
present
formula
Prior art date
Application number
BR112022002269A
Other languages
English (en)
Inventor
Kiyotaka Matsui
Masahiro Ito
Masami Inuma
Original Assignee
Sato Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sato Pharma filed Critical Sato Pharma
Publication of BR112022002269A2 publication Critical patent/BR112022002269A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

a presente invenção provê uma técnica para permitir que esta composição farmacêutica que contém luliconazol ou similar e que é preferivelmente para uso tópico, contenha luliconazol ou similar em uma alta concentração e iniba a precipitação do mesmo ao longo do tempo. a presente invenção usa, em combinação, um polietilenoglicol representado por uma fórmula hoch2(ch2och2)nch2oh (na fórmula, n representa um número inteiro) e tendo um peso molecular médio de 380 a 420, etanol, álcool benzílico, ácido lático, carbonato de propileno e acetona.
BR112022002269A 2019-08-13 2020-08-07 Composição farmacêutica, e, método para preparar a composição farmacêutica BR112022002269A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019148620 2019-08-13
PCT/JP2020/030350 WO2021029350A1 (ja) 2019-08-13 2020-08-07 抗真菌薬を有効成分とする医薬組成物

Publications (1)

Publication Number Publication Date
BR112022002269A2 true BR112022002269A2 (pt) 2022-04-19

Family

ID=74190800

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022002269A BR112022002269A2 (pt) 2019-08-13 2020-08-07 Composição farmacêutica, e, método para preparar a composição farmacêutica

Country Status (12)

Country Link
US (2) US10898470B1 (pt)
EP (1) EP4015042A4 (pt)
JP (1) JP6888180B1 (pt)
KR (1) KR20220035954A (pt)
CN (1) CN114206387A (pt)
AU (1) AU2020327775B2 (pt)
BR (1) BR112022002269A2 (pt)
CA (1) CA3149802A1 (pt)
CL (1) CL2022000330A1 (pt)
MX (1) MX2022001601A (pt)
NZ (1) NZ785310A (pt)
WO (1) WO2021029350A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10898470B1 (en) * 2019-08-13 2021-01-26 Sato Pharmaceutical Co., Ltd. Pharmaceutical composition containing antifungal agent as active ingredient
AU2022297596A1 (en) 2021-06-25 2024-01-04 Schlumberger Technology B.V. Cutting tool and controls for downhole mechanical services
WO2024024520A1 (ja) * 2022-07-28 2024-02-01 花王株式会社 外用剤組成物

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5345937B2 (pt) 1974-04-26 1978-12-09
JPS5412723A (en) 1977-06-29 1979-01-30 Bodysonic Kk Attentant feeling reproducing unit
US4162470A (en) 1977-07-26 1979-07-24 Rca Corporation Magnetizing apparatus and method for producing a statically converged cathode ray tube and product thereof
JPS5496659A (en) 1978-01-17 1979-07-31 Nissan Motor Co Ltd Automatic transmission gear
JPS54119654A (en) 1978-03-08 1979-09-17 Daikou Tetsukou Kk Method of producing cylindrical fuse
JPS5938497B2 (ja) 1980-02-25 1984-09-17 日立プラント建設株式会社 風量制御装置
JPH06211651A (ja) 1993-01-12 1994-08-02 Hisamitsu Pharmaceut Co Inc 爪白癬治療用組成物
JP3803393B2 (ja) 1994-01-12 2006-08-02 久光製薬株式会社 爪白癬治療用組成物
AU3673195A (en) 1994-10-13 1996-05-06 Hisamitsu Pharmaceutical Co., Inc. External preparation for nail ringworm
US5900488A (en) 1995-07-08 1999-05-04 Nihon Nohyaku Co., Ltd. Method for treating mycosis using imidazolylacetonitrile derivatives
JP3278738B2 (ja) 1995-07-08 2002-04-30 日本農薬株式会社 抗真菌剤
JP4253047B2 (ja) 1996-09-27 2009-04-08 杏林製薬株式会社 被膜形成性抗真菌剤組成物
US6585963B1 (en) 2001-02-15 2003-07-01 Watson Pharmaceuticals, Inc. Nail compositions and methods of administering same
JP5160409B2 (ja) 2006-03-08 2013-03-13 日本農薬株式会社 外用の医薬組成物
MX2008011433A (es) 2006-03-08 2008-09-18 Nihon Nohyaku Co Ltd Composicion farmaceutica para uso externo.
EP2005959B1 (en) 2006-03-08 2015-01-21 Nihon Nohyaku Co., Ltd. Pharmaceutical composition for external use
PL2191828T3 (pl) * 2007-09-05 2017-02-28 Pola Pharma Inc. Przeciwgrzybicza kompozycja farmaceutyczna
CN101808637B (zh) 2007-09-05 2013-07-24 宝丽制药股份有限公司 医药组合物
WO2009031643A1 (ja) 2007-09-05 2009-03-12 Pola Pharma Inc. 抗真菌組成物
CN102395274B (zh) 2009-02-13 2014-03-12 托派卡医药股份有限公司 抗真菌制剂
WO2010117091A2 (en) 2009-04-09 2010-10-14 Pola Pharma Inc. Antimycotic pharmaceutical composition
US10130610B2 (en) 2009-04-09 2018-11-20 Pola Pharma Inc. Antimycotic pharmaceutical composition
KR101754697B1 (ko) 2009-08-25 2017-07-06 가부시키가이샤 폴라 파마 항진균성 약제학적 조성물
US8962669B2 (en) 2010-06-11 2015-02-24 Pola Pharma Inc. Antimycotic pharmaceutical composition
JP5686874B2 (ja) 2012-09-14 2015-03-18 株式会社ポーラファルマ 医薬組成物
JP2014114249A (ja) 2012-12-11 2014-06-26 Kanae Technos:Kk 基剤、及び皮膚外用剤
JP5587488B1 (ja) * 2013-12-12 2014-09-10 株式会社ポーラファルマ ルリコナゾールを含有する製剤の評価方法及び指標物質
WO2017216722A2 (en) * 2016-06-13 2017-12-21 Vyome Biosciences Pvt. Ltd. Synergistic antifungal compositions and methods thereof
US10898470B1 (en) * 2019-08-13 2021-01-26 Sato Pharmaceutical Co., Ltd. Pharmaceutical composition containing antifungal agent as active ingredient

Also Published As

Publication number Publication date
JP6888180B1 (ja) 2021-06-16
WO2021029350A1 (ja) 2021-02-18
US10898470B1 (en) 2021-01-26
US11738006B2 (en) 2023-08-29
US20210046052A1 (en) 2021-02-18
MX2022001601A (es) 2022-03-11
AU2020327775A1 (en) 2022-03-10
JPWO2021029350A1 (ja) 2021-09-13
CA3149802A1 (en) 2021-02-18
US20210220338A1 (en) 2021-07-22
AU2020327775B2 (en) 2023-06-08
NZ785310A (en) 2024-05-31
KR20220035954A (ko) 2022-03-22
EP4015042A1 (en) 2022-06-22
CL2022000330A1 (es) 2022-10-21
CN114206387A (zh) 2022-03-18
EP4015042A4 (en) 2023-06-07
TW202114661A (zh) 2021-04-16

Similar Documents

Publication Publication Date Title
BR112022002269A2 (pt) Composição farmacêutica, e, método para preparar a composição farmacêutica
BR112022024943A2 (pt) Composição oral efervescente compreendendo um ingrediente ativo
BRPI0621386B8 (pt) composição farmacêutica para o uso externo
ECSP056029A (es) Formulación para un inhalador con dosis medida que emplea hidrofluoroalcanos como propulsores
AR055319A1 (es) Derivados de isoquinoleina, composiciones farmaceuticas y usos
BRPI0615898B8 (pt) composição farmacêutica, e, uso de um composto ou de um sal, um solvato, um hidrato ou uma forma morfológica do mesmo farmaceuticamente aceitável
ES2621809T3 (es) Inhibidores de TFPI y procedimientos de uso
BR112017028359A2 (pt) aditivo de cimento, composição de cimento, e matéria-prima para aditivo de cimento
WO2012084701A3 (en) Cosmetic composition comprising a cucurbic acid compound and a hydrophobic inulin
ES2664975T3 (es) Películas hidrosolubles que comprenden alginatos de baja viscosidad
BR112018069050A2 (pt) composição aquosa de ligação
BR112020022193A8 (pt) Composições que contêm sal de glufosinato e um sal de herbicida de auxina sintética
CO2022004978A2 (es) Inhibidor de irak y método de preparación para el mismo y uso del mismo
BRPI0511135A (pt) formulação de aerossol para a inalação de beta-agonistas
BR112021024063A2 (pt) Identificação e seleção de um material de partida vegetal de sulfato de condroitina vegetal e ácido hialurônico, e transformação de tal material de partida vegetal para obter ingredientes para uso em alimentos, suplementos, dispositivos médicos ou fármacos
BR112015004220A2 (pt) composições para o tratamento de psoríase
BR112015001006A2 (pt) composições farmacêuticas contendo ácido lático oligomérico
BRPI0214180B8 (pt) composição fungicida sinérgica, método de controle curativo ou preventivo e produto
PT1474490E (pt) Composicoes contendo aductos de ciclopentadieno e sua utilizacao para revestimentos resistentes a produtos quimicos
BRPI0403991A (pt) Composição útil para a produção de uma espuma de poliuretano
BR112017012181A2 (pt) composição de resina de álcool polimetalílico e corpo moldado que contém a mesma
BR112023003472A2 (pt) Composição geradora de aerossol, artigo, sistema de provisão de aerossol e seu uso, pasta, método de produção de uma composição geradora de aerossol, método para gerar um aerossol
ATE344654T1 (de) Kosmetische oder pharmazeutische zusammensetzung enthaltend einen extrakt einer braunalge der art halopteris
BR112021025679A2 (pt) Composição adesiva de retorta à base de solvente, adesivo, processos para a produção de uma composição adesiva e para a produção de um produto laminado, produto laminado de múltiplas camadas, e, recipiente para embalagem de retorta
BR112022008208A2 (pt) Compostos de d-anfetamina, composições e processos para produzir e usar os mesmos

Legal Events

Date Code Title Description
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]